SKYRIZI® Gains FDA Approval for Use in Children with Psoriatic Disease AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of…
Novo Nordisk to Showcase New Haemophilia Research and Investigational Denecimig Data at ISTH 2026 Congress Novo Nordisk has announced that it will present an extensive portfolio of new scientific data…
Epicrispr Biotechnologies Reports Promising Phase 1/2 Data Showing Increased Muscle Volume with EPI-321 in Patients with Facioscapulohumeral Muscular Dystrophy Epicrispr Biotechnologies, a clinical-stage biotechnology company focused on developing epigenetic therapies,…
Incyte Receives Positive CHMP Opinion for Opzelura® Cream in Adults with Moderate Atopic Dermatitis Incyte has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European…
CHMP Recommends EU Approval of DAYBUE® (trofinetide) Acadia Pharmaceuticals Inc. has announced a significant regulatory milestone for its rare disease portfolio after the Committee for Medicinal Products for Human Use…
Stallergenes Greer Earns 2026 Switzerland’s Best Managed Companies Award for Excellence in Leadership, Innovation, and Sustainable Growth Stallergenes Greer, a global leader in allergy immunotherapy and allergy care, has been…
MaaT Pharma to Seek EMA Re-Examination After CHMP Issues Negative Opinion on Conditional Marketing Application for Xervyteg® in Acute Graft-versus-Host Disease Clinical-stage biotechnology company MaaT Pharma has announced that the…
FIRST Survey Highlights the Emotional, Social, and Daily Challenges Faced by People Living with Ichthyosis, Reinforcing the Need for Better Treatments and Support The Foundation for Ichthyosis & Related Skin…
MRM Health Strengthens Board of Directors with Two Industry Veterans as Lead Microbiome Therapy Advances Toward Late-Stage Development MRM Health, a clinical-stage biotechnology company focused on developing microbiome-based therapeutics for…
Elevation Spine Surpasses 5,000 Saber-C Implantations, Highlighting Growing Adoption of Its Integrated Cervical Fusion Technology Elevation Spine has announced a significant milestone for its cervical spine portfolio, revealing that more…
Trodelvy® is now FDA-approved as a first-line treatment option for patients with metastatic triple-negative breast cancer, expanding its role in frontline care. Gilead Sciences has secured a major new U.S.…
Carnegie Mellon-Led Team Secures Up to $39.3 Million ARPA-H Award to Develop OMEGA Fetal Monitoring System Carnegie Mellon University is spearheading a major multi-institution research initiative aimed at transforming how…